/
OFIX
$9.68-$0.10 (-1.02%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$395.3M
40M shares
52-week range
$8.85 – $16.99
10% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Borrow rate
0.80%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-30.43
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $453.0M | $460.0M | $406.6M | $464.5M | $460.7M | $746.6M | $799.5M | $822.3M |
| Cost of revenue | $96.6M | $100.6M | $101.9M | $114.9M | $123.5M | $260.4M | $253.6M | $270.6M |
| Gross profit | $356.4M | $359.3M | $304.7M | $349.6M | $337.2M | $486.3M | $545.9M | $551.7M |
| Gross margin | 78.7% | 78.1% | 74.9% | 75.3% | 73.2% | 65.1% | 68.3% | 67.1% |
| R&D | $33.2M | $34.6M | $39.1M | $49.6M | $49.1M | $80.2M | $73.6M | $57.1M |
| Operating income | $30.1M | −$18.8M | −$6.3M | −$8.3M | −$13.3M | −$139.1M | −$84.6M | −$68.5M |
| EBITDA | $41.5M | $1.6M | $36.4M | $21.4M | $15.7M | −$79.5M | −$34.2M | −$22.4M |
| Net income | $13.8M | −$28.5M | $2.5M | −$38.4M | −$19.7M | −$151.4M | −$126.0M | −$92.2M |
| Net margin | 3.0% | -6.2% | 0.6% | -8.3% | -4.3% | -20.3% | -15.8% | -11.2% |
| EPS (diluted) | 0.73 | -1.51 | 0.13 | -1.95 | -0.98 | -4.12 | -3.30 | -2.28 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $841M | $-1.22 | $-1.23–$-1.21 | 1 |
| 2027 | $881M | $-1.01 | $-1.02–$-1.00 | 1 |
| 2028 | $931M | $-0.57 | $-1.07–$-0.08 | 2 |
| 2029 | $1.0B | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Orthofix Medical Inc. Common Stock (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
www.orthofix.com- Employees
- 1,605
- IPO / List date
- Apr 24, 1992
- HQ
- LEWISVILLE, TX
Held by traders on TradeandTell
No one on the platform currently holds OFIX.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 101,991 | $1.2M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded OFIX yet.
